Apoptosis and related proteins in different stages of human atherosclerotic plaques

Circulation

Volumn 97, Issue 23, 1998, Pages 2307-2315

  Kockx, Mark M ^a   De Meyer, Guido R Y ^b   Muhring, Johannes ^a   Jacob, Willem ^b   Bult, Hidde ^b   Herman, Arnold G ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apoptosis; Atherosclerosis; Carotid arteries; Cells; Cholesterol; Muscle, smooth

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID SINUS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0032537609     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.23.2307     Document Type: Article

References (44)

1. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
2. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Am J Pathol. 1995;147:251-266.
3. Man DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
4. Kockx MM, De Meyer GRY, Muhring J, Bull H, Bultinck J, Herman A. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis. 1996;120:115-124.
5. Kockx MM, Cambier BA, Bortier HE, De Meyer GR, Declercq SC, Van Cauwelaert PA, Bultinck J. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology. 1994;25:365-371.
6. Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
7. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
8. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CY, van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993;41:7-12.
9. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol. 1993;170:1-8.
10. Hegyi L, Skepper JN, Cary NR, Mitchinson MJ. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 1996;180:423-442.
11. Kockx MM, Muhring J, Bortier H, De Meyer GRY, Jacob W. Biotin or digoxigenin conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 1996;148:1771-1777.
12. Kockx MM, De Meyer GRY, Bortier H, de Meyere N, Muhring J, Bakker A, Jacob W, Van Vaeck L, Herman A. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation. 1996;94:1255-1262.
13. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin Cell Biol. 1995;7:337-343.
14. Bennet MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
15. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1512-1531.
16. Glagov S, Zarins CK, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988;112:1018-1031.
17. Guyton JR, Klemp KF. Transitional features in human atherosclerosis: intimal thickening, cholesterol clefts and cell loss in human aortic fatty streaks. Am J Pathol. 1993;143:1444-1457.
18. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation. 1996;94:2013-2020.
19. Katsuda S, Boyd HC, Fligner C, Ross R, Gown AM. Human atherosclerosis, III: immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 1992;140:907-914.
20. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis. I: cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984;114:79-93.
21. Stehbens WE. Cerebral atherosclerosis: intimal proliferation and atherosclerosis in the cerebral arteries. Arch Pathol. 1975;999:582-591.
22. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
23. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
24. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Circulation. 1994;90:775-778.
25. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347:1447-1449.
26. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 1996;7:330-335.
27. Newby AC, George SJ. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr Opin Cardiol. 1996;11:574-582.
28. Gallis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
29. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J Clin Invest. 1996;98:2572-2579.
30. Schiomi M, Ito T, Tsukada T, Yata T, Ueda M. Cell composition of coronary and aortic atherosclerotic atherosclerotic lesions in WHHL rabbits differs: an immunohistochemical study. Arterioscler Thromb. 1994;14:931-937.
31. Lei X, Buja LM. Measurement by quantitative reverse transcription-polymerase chain reaction of the levels of tumor necrosis factor alpha mRNA in atherosclerotic arteries in Watanabe heritable hyperlipidemic rabbits. Lab Invest. 1996;74:136-145.
32. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983;24:1070-1076.
33. Jimi S, Sakata N, Takebayashi S. Oxidized LDL induces an increase in the relative collagen synthesis of rabbit aortic smooth muscle cells. Arterioscler Thromb. 1994;1:53-59.
34. Reid VC, Mitchinson MJ, Shepper JN. Cytotoxicity of oxidized low density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J Pathol. 1993;171:321-328.
35. 1 macrophages exposed to oxidised low density lipoprotein. FEBS Lett. 1993;332:218-220.
36. Björkerud B, Björkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol. 1996;16:416-424.
37. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1 β. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
38. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994, 124:1-6.
39. Oltvai ZH, Milliman CL, Korsmeyer SJ. BCL-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
40. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of BAX, a dominant inhibitor of BCL-2. Am J Pathol. 1994;145:1323-1336.
41. Xiang J, Chao DT, Korsmeyer SJ. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl Acad Sci U S A. 1996;93:14559-14563.
42. Yen ETH. Life and death in the cardiovascular system. Circulation. 1997;95:782-786.
43. Nishio E, Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and BCL-2 protein down-regulation. Biochem Biophys Res Commun. 1996;226:928-934.
44. Mallat Z, Ohan J, Lesèche G, Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 1997;96:424-428.